NORCROSS, Ga.--(BUSINESS WIRE)--AerovectRx Corporation, an aerosol drug delivery and therapeutics company, announced the appointment of David Johnston, Ph.D. to its Board of Directors. Dr. Johnston is a senior pharmaceutical executive with extensive experience in preclinical and clinical drug development, regulatory affairs and product commercialization.
